Completed PHASE2 INTERVENTIONAL 2-arm NCT02610491

The Effect of Hesperidin on Glucose / Insulin Metabolism

The Effect of Hesperidin Administration on Glucose / Insulin Metabolism

Sponsor: Maastricht University Medical Center

Updated 5 times since 2017 Last updated: Nov 19, 2015 Started: Feb 28, 2015 Primary completion: Oct 31, 2015 Completion: Oct 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02610491, this PHASE2 trial focuses on Metabolic Syndrome and Obesity and remains completed. Sponsored by Maastricht University Medical Center, it has been updated 5 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Maastricht University Medical Center

Data source: Maastricht University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Maastricht, Netherlands